Press Release

Categories:

Press Release

SpiroChem and Domainex enter a fragment drug discovery partnership.

Mar 20 2019

Saffron Walden, UK, and Basel, Switzerland 20 March 2019 SpiroChem AG specializes in the design and synthesis of proprietary collections of sp3-rich molecular fragments and associated synthetic cap...

A word from Dr. Thomas Fessard, CEO @ SpiroChem.

Press Release

Aug 21 2018

A word from Dr. Thomas Fessard, CEO @ SpiroChem.

Annual Summary 2017 - On track for ambitious growth path.

Press Release

Mar 05 2018

Annual Summary 2017 - On track for ambitious growth path.

SpiroChem AG successfully completes fundraise to support accelerated growth.

Press Release

Dec 13 2017

SpiroChem AG successfully completes fundraise to support accelerated growth.

SpiroChem opens new state-of-the-art Services and R&D facilities in Basel, Switzerland and Strengthens Board of Directors.

Press Release

Sep 29 2017

SpiroChem opens new state-of-the-art Services and R&D facilities in Basel, Switzerland and Strengthens Board of Directors.

Improving Nonspecific Binding and Solubility: BicycloalkylGroups and Cubanes as para-Phenyl Bioisosteres | ChemMedChem Article - SpiroChem.

Press Release

Apr 19 2017

Improving Nonspecific Binding and Solubility: BicycloalkylGroups and Cubanes as para-Phenyl Bioisosteres | ChemMedChem Article - SpiroChem.

Interview of Thomas C. Fessard in Handelszeitung.

Press Release

May 30 2016

Interview of Thomas C. Fessard in Handelszeitung.

Press Release

Jan 26 2016

CTI grant from the Swiss Government.

Press Release

Sep 10 2015

Venture Leaders 2015.

SpiroChem - One of the 50 Swiss start-ups in which to invest.

Press Release

Feb 04 2015

Chemistry News

Press Release

SpiroChem and Domainex enter a fragment drug discovery partnership.

Newsletter

Don’t miss out on what is important.